Gilead Sciences (GILD) 104.18 $GILD Forget Google: 5 Top

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 104.18 $GILD

Forget Google: 5 Top Stocks With Earnings Thursday
at Investor's Business Daily - 1 hr 10 mins ago
Tech titan Google (GOOGL) will make headlines with its quarterly earnings after the close on Thursday. But Google's growth is sluggish and the stock is lackluster. Check out these five stocks with better performance than the search giant, including...
AMZN: 389.80 (-1.38), PCYC: 256.98 (-0.77), MO: 52.12 (+0.02), ALK: 64.31 (-0.62), LUV: 42.85 (-0.18), SBUX: 48.33 (-0.04), GILD: 104.18 (-1.02), ALXN: 188.19 (+1.41), GM: 37.16 (unch), GOOGL: 549.18 (+6.26), ABBV: 64.52 (+0.91), PG: 83.09 (+0.01), MSFT: 42.98 (+0.35), DOW: 50.02 (+0.37)

Final Glance: Biotechnology companies
AP - 2 hrs 28 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

The Fed And The Markets: Where To Invest In The Current Environment
Nicholas P. Cheer - at Seeking Alpha - Wed Apr 22, 1:08PM CDT

JNJ: 100.43 (+0.13), BIIB: 423.57 (+1.46), BOND: 109.71 (-0.57), USB: 42.83 (+0.33), GILD: 104.18 (-1.02), AIG: 56.58 (-0.06), AAPL: 128.62 (+1.71), TLT: 127.72 (-1.98)

The Naked Truth
Eric Parnell, CFA - at Seeking Alpha - Wed Apr 22, 1:04PM CDT

SPLV: 37.76 (+0.11), IEF: 107.92 (-0.63), EZU: 39.22 (unch), XLU: 44.45 (+0.09), TLT: 127.72 (-1.98), XLV: 74.35 (+0.12), EWJ: 13.27 (+0.10), XLP: 49.35 (+0.03), SPY: 210.63 (+1.03), GILD: 104.18 (-1.02), GLD: 113.83 (-1.55), PFF: 39.98 (+0.02), VNQ: 82.23 (+0.17), BWX: 53.17 (-0.07), FXI: 52.39 (+0.89)

Gilead hopes to drive international demand for hep C drugs by giving some away
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 1:01PM CDT

GILD: 104.18 (-1.02), ABBV: 64.52 (+0.91)

Midday Glance: Biotechnology companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 22, 12:21PM CDT
Amgen's (AMGN) first quarter 2015 results were impressive and the company raised its earnings outlook for the year.
BIIB: 423.57 (+1.46), ALNY: 118.00 (-2.70), GILD: 104.18 (-1.02), MDCO: 27.84 (+0.25), AMGN: 169.10 (+0.64), AMPE: 2.89 (+0.20), ABBV: 64.52 (+0.91), ATHX: 1.34 (+0.01)

Gilead Sciences (GILD) Stock Is the 'Chart of the Day'
at The Street - Wed Apr 22, 11:20AM CDT
Gilead Sciences (GILD) stock is the Trifecta Stocks Team's 'Chart of the Day.'
GILD: 104.18 (-1.02)

Gilead Buying Vertex? What's The Use?
Kanak Kanti De - at Seeking Alpha - Wed Apr 22, 10:39AM CDT

VRTX: 132.85 (+0.65), GILD: 104.18 (-1.02)

Early Glance: Biotechnology companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Amgen Earnings Reveals Ugly Truth About Drug Pricing and Sales 'Growth'
at The Street - Wed Apr 22, 9:18AM CDT
It's common for drug companies to raise the price of their existing products once or twice per year, every year. The price increases far outpace the rate of inflation.
BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:30AM CDT
The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals
JNJ: 100.43 (+0.13), BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), ANTH: 4.79 (+0.10), GERN: 4.20 (-0.04)

Gilead Sciences Vs. AbbVie: Which Is A Better Buy?
Mycroft - at Seeking Alpha - Wed Apr 22, 7:49AM CDT

JNJ: 100.43 (+0.13), ABT: 48.35 (+1.23), PCYC: 256.98 (-0.77), GILD: 104.18 (-1.02), SHPG: 253.58 (+3.70), ABBV: 64.52 (+0.91)

Gilead Sciences
at Investor's Business Daily - Tue Apr 21, 5:48PM CDT
Gilead Sciences (GILD) stock rose 4.5% after Bernstein said it should buy cystic fibrosis drugmaker Vertex (VRTX), which rose 5%.
VRTX: 132.85 (+0.65), GILD: 104.18 (-1.02)

SmarTrend Watching for Potential Pullback in Shares of Gilead Sciences After 4.52% Gain
Comtex SmarTrend(R) - Tue Apr 21, 3:46PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $100.89 to a high of $105.71. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $104.72 on volume of 19.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GILD: 104.18 (-1.02)

Gilead Sciences Rises 4.52% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 21, 3:45PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $100.89 to a high of $105.71. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $104.72 on volume of 19.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GILD: 104.18 (-1.02)

Dow Extends Losses; Travelers Falls After Missing Earnings Estimates
at The Street - Tue Apr 21, 2:16PM CDT
Stocks are mixed on Tuesday as disappointing earnings drag on overall markets.
HOG: 56.23 (+0.51), VRTX: 132.85 (+0.65), UTX: 116.96 (+0.01), MYL: 72.40 (-1.67), PKG: 70.68 (+1.66), UA: 82.27 (-1.25), GILD: 104.18 (-1.02), IBM: 165.36 (+1.10), DD: 71.44 (+0.75), TEVA: 63.01 (-1.15), VZ: 49.57 (+0.40), BHI: 67.07 (-0.28), TRV: 102.02 (+0.14)

5 Reasons To Consider Gilead
David Sims - at Seeking Alpha - Tue Apr 21, 1:02PM CDT

GILD: 104.18 (-1.02), ABBV: 64.52 (+0.91)

Most active Nasdaq-traded stocks
AP - Tue Apr 21, 12:45PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
GILD: 104.18 (-1.02), AMD: 2.28 (-0.07), FB: 84.63 (+1.01), BIOC: 3.15 (+0.02), CMCSK: 58.35 (-0.09), AXPW: 0.04 (unch), VLTC: 15.14 (-1.04), MSFT: 42.98 (+0.35), ZNGA: 2.51 (+0.02), AAPL: 128.62 (+1.71), CMCSA: 58.76 (-0.08), CSCO: 28.62 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
AI Agents Redefine Finance: Deutsche & Ant Tech

Updated Category News Views 42

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 95

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 151

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 50

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 513

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 323

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 723

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 124

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading

Top 5 Most Recently Viewed Articles

Westgold Resources Initiates Mining Operations at South Junction

Updated Category News Views 110

Westgold Resources Launches Mining Operations at South Junction Westgold Resources Limited (ASX: WGX, OTCQX: WGXRF) has officially kicked off mining activities at the South Junction Lode, which is part of its Bluebird-South Junction mining complex located in Meekatharra. This marks an important milestone for the company as it aims to boost production in this crucial area....

Continue Reading
Inspira Apartments: A Florida Gem hits the Market

Updated Category News Views 37

Spotlight on Inspira Apartments in Naples Alright folks, Naples isn't just about sunshine and retirees lounging in their flip-flops. A real estate ripper-known as JBM® just threw the Inspira Apartments into the investment ring, with a Call For Offers set for July 30th, 2026. This isn’t your average cookie-cutter deal; it’s a top-tier, institutional-grade gem with 304...

Continue Reading
TechSee Welcomes Domenico D'Ambrosio to Advisory Board to Enhance AI Strategy

Updated Category News Views 233

TechSee Strengthens Advisory Board with Key Appointment TechSee, a household name in the telecom and technology landscape, is taking a significant step towards redefining customer experiences by welcoming Domenico D'Ambrosio to its Advisory Board. This strategic move aims to enhance the direction of the company as it ventures deeper into the world of Agentic AI, a...

Continue Reading
Human Longevity, Inc. Launches Advanced Pancreatic Cancer Test

Updated Category News Views 256

Human Longevity, Inc. Launches Advanced Pancreatic Cancer Test Human Longevity, Inc. (HLI), a frontrunner in the field of precision health, has recently enhanced its cancer prevention offerings. The company has introduced the ClearNote Health Avantect Pancreatic Cancer Test into its portfolio, designed to assist clients in detecting pancreatic cancer in its early stages....

Continue Reading
Idorsia Moves Forward After Ending Aprocitentan Exclusivity Deal

Updated Category News Views 408

Idorsia Announces Conclusion of Aprocitentan Exclusivity Agreement Idorsia Ltd has recently made a significant announcement regarding their drug, aprocitentan. The exclusivity agreement that was in place since November 2024 with an undisclosed partner has come to an end. This development was confirmed as the prospective partner chose not to finalize the deal, which...

Continue Reading